COMP-Angiopoietin-1 ameliorates surgery-induced ischemic necrosis of the femoral head in rats

Bone

Volumn 44, Issue 5, 2009, Pages 886-892

  Park, Byung Hyun ^a   Jang, Kyu Yun ^a   Kim, Kyu Hyung ^a   Song, Kwang Hun ^a   Lee, Sang Yong ^a   Yoon, Sun Jung ^a   Kwon, Keun Sang ^a   Yoo, Wan Hee ^a   Koh, Young Jun ^b   Yoon, Kwon Ha ^c   Son, Hyun Hwa ^c   Koh, Gou Young ^b   Kim, Jung Ryul ^a  

^a Research Institute of Clinical Medicine   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

Angiogenesis; COMP Ang1; Femoral head; Ischemic necrosis; Osteogenesis

Indexed keywords

ANGIOPOIETIN 1; BOVINE SERUM ALBUMIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REMODELING; CONTROLLED STUDY; FEMUR HEAD; FEMUR HEAD NECROSIS; FRACTURE HEALING; MALE; NONHUMAN; OSSIFICATION; RAT;

ANGIOPOIETIN-1; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; FEMUR HEAD; FEMUR HEAD NECROSIS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAOSSEOUS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 63449107665     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.01.366     Document Type: Article

References (31)

1. Bejar J., Peled E., and Boss J.H. Vasculature deprivation-induced osteonecrosis of the rat femoral head as a model for therapeutic trials. Theor. Biol. Med. Model 2 (2005) 24
2. Kerachian M.A., Harvey E.J., Cournoyer D., Chow T.Y., and Seguin C. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13 (2006) 237-244
3. Assouline-Dayan Y., Chang C., Greenspan A., Shoenfeld Y., and Gershwin M.E. Pathogenesis and natural history of osteonecrosis. Semin. Arthritis Rheum. 32 (2002) 94-124
4. McAndrew M.P., and Weinstein S.L. A long-term follow-up of Legg-Calve-Perthes disease. J. Bone Joint Surg. Am. 66 (1984) 860-869
5. Aya-ay J., Athavale S., Morgan-Bagley S., Bian H., Bauss F., and Kim H.K. Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head. J. Bone Miner. Res. 22 (2007) 93-100
6. Winet H. The role of microvasculature in normal and perturbed bone healing as revealed by intravital microscopy. Bone 19 (1996) 39S-57S
7. Geiger F., Bertram H., Berger I., Lorenz H., Wall O., Eckhardt C., et al. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J. Bone Miner. Res. 20 (2005) 2028-2035
8. Katsube K., Bishop A.T., Simari R.D., Yla-Herttuala S., and Friedrich P.F. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone. J. Orthop. Res. 23 (2005) 469-474
9. Ma H.Z., Zeng B.F., and Li X.L. Upregulation of VEGF in subchondral bone of necrotic femoral heads in rabbits with use of extracorporeal shock waves. Calcif. Tissue Int. 81 (2007) 124-131
10. Vadasz Z., Misselevich I., Norman D., Peled E., and Boss J.H. Localization of vascular endothelial growth factor during the early reparative phase of the rats' vessels deprivation-induced osteonecrosis of the femoral heads. Exp. Mol. Pathol. 77 (2004) 145-148
11. Galeano M., Deodato B., Altavilla D., Cucinotta D., Arsic N., Marini H., et al. Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 46 (2003) 546-555
12. Galiano R.D., Tepper O.M., Pelo C.R., Bhatt K.A., Callaghan M., Bastidas N., et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am. J. Pathol. 164 (2004) 1935-1947
13. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
14. Cho C.H., Kim K.E., Byun J., Jang H.S., Kim D.K., Baluk P., et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ. Res. 97 (2005) 86-94
15. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (1996) 1161-1169
16. Saharinen P., Kerkela K., Ekman N., Marron M., Brindle N., Lee G.M., et al. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J. Cell Biol. 169 (2005) 239-243
17. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
18. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6 (2000) 460-463
19. Cho C.H., Kammerer R.A., Lee H.J., Steinmetz M.O., Ryu Y.S., Lee S.H., et al. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5547-5552
20. Mose K. Methods of measuring in Legg-Calve-Perthes disease with special regard to the prognosis. Clin. Orthop. Relat. Res. (1980) 103-109
21. Valtola R., Salven P., Heikkila P., Taipale J., Joensuu H., Rehn M., et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 154 (1999) 1381-1390
22. Cho C.H., Sung H.K., Kim K.T., Cheon H.G., Oh G.T., Hong H.J., et al. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 4946-4951
23. Kim W., Moon S.O., Lee S.Y., Jang K.Y., Cho C.H., Koh G.Y., et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J. Am. Soc. Nephrol. 17 (2006) 2474-2483
24. Lee S., Kim W., Moon S.O., Sung M.J., Kim D.H., Kang K.P., et al. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol. Dial. Transplant. 22 (2007) 396-408
25. Bejar J., Misselevich I., Peled E., Zinman C., Reis D.N., and Boss J.H. Pyogenic granuloma-like reaction in the necrotic, vessels-deprived femoral head of the rat. Exp. Mol. Pathol. 78 (2005) 140-143
26. Zhao C., Irie N., Takada Y., Shimoda K., Miyamoto T., Nishiwaki T., et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 4 (2006) 111-121
27. Tanaka Y., Abe M., Hiasa M., Oda A., Amou H., Nakano A., et al. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin. Clin. Cancer Res. 13 (2007) 816-823
28. 3-integrin. Matrix Biol. 27 (2008) 589-599
29. Collin-Osdoby P., Rothe L., Bekker S., Anderson F., Huang Y., and Osdoby P. Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J. Bone Miner. Res. 17 (2002) 1859-1871
30. Dai J., and Rabie A.B. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J. Dent. Res. 86 (2007) 937-950
31. Suzuki T., Miyamoto T., Fujita N., Ninomiya K., Iwasaki R., Toyama Y., et al. Osteoblast-specific angiopoietin 1 overexpression increases bone mass. Biochem. Biophys. Res. Commun. 362 (2007) 1019-1025